• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Baxter has a serious infusion pump recall

October 29, 2020 By Chris Newmarker

BaxterBaxter (NYSE:BAX) has issued an urgent device correction involving hundreds of thousands of Sigma Spectrum infusion pumps in which it warns that improper cleaning could cause corrosion around the batteries.

So far, Baxter has received 16 reports of serious injuries related to the problem. FDA has labeled the recall as Class I, its most serious level. FDA said the recall involved 306,617 units of the Baxter Sigma Spectrum Infusion Pump with Master Drug Library (Version 8).

“I’d like to emphasize that this is not a new issue. We alerted customers and FDA to the risks related to improper cleaning of the pumps months ago, and are working on updating the Instructions for Use to provide additional information,” Baxter spokesperson Bess Featherstone told Drug Delivery Business News and MassDevice.

“FDA’s classification of the recall simply comes once the agency completes their risk review. Also, customers can continue to safely use their pumps while following the instructions for cleaning in their Operator’s Manuals,” Featherstone added.

If health providers deviate from cleaning methods described in product-specific operator’s manuals, there could be residue buildup or corrosion of the electrical pins on the infusion pump rear case and battery electrical contacts, Baxter said in its announcement that FDA posted yesterday. Notifications could start popping up that users should check the battery or that batteries are not charging or holding their charge.

Baxter said a corroded Sigma Spectrum infusion pump running solely on battery power could shut down without alerting the user, a potentially deadly situation depending on the type of medication involved and the volume and rate of infusion.

On top of calling for adherence to cleaning instructions, Baxter is asking health providers using the infusion pumps to check the rear case electrical pins and battery electrical contacts for residue buildup or corrosion and depressed pins. The Deerfield, Ill.–based company also recommended other precautions, including having backup devices readily available and keeping the infusion pumps connected to AC power as much as possible.

Filed Under: Featured, Food & Drug Administration (FDA), Recalls Tagged With: Baxter, infusion systems

IN CASE YOU MISSED IT

  • 8 drug delivery innovations you need to know
  • Axonics acquires Contura and its Bulkamid bulking agent for $235M
  • Lilly to add Welldoc app to future insulin pen
  • Kala Pharmaceuticals slides on missed Q4 projections
  • Semaglutide paired with behavioral therapy tripled weight loss in trial

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS